YM BioSciences Inc. (YM) - Medical Equipment - Deals and Alliances Profile

Document Sample
YM BioSciences Inc. (YM) - Medical Equipment - Deals and Alliances Profile Powered By Docstoc
					         YM BioSciences Inc. (YM) - Medical Equipment - Deals and Alliances Profile
       Reference Code: GDME10230D                                                                                                                 Publication Date: JUN 2013

      Company Overview                                                                                         Key Facts
      YM BioSciences Inc. (YM BioSciences) is a life sciences product development
                                                                                                               YM BioSciences Inc., Medical Equipment, Key
      company. It focuses on the advancement of three clinical-stage hematology and
                                                                                                               Facts, 2012
      oncology products, namely, CYT387, nimotuzumab, and CYT997.
                                                                                                                Web Address                              www.ymbiosciences.co
                                                                                                                                                         m
                                                                                                                Revenue (US$ million)                                          1.08
                                                                                                                Number of Employees                                             32
                                                                                                                GlobalData

      Financial Deals Landscape
        YM BioSciences Inc., Medical Equipment, Deals by Type, 2007 to                     YM BioSciences Inc., Medical Equipment, Deals By Year,
        YTD 2013                                                                           2007 to YTD 2013


                                                                                                                                              2
                                                                                                           2



                                                                                            No. of Deals
                                                                                                                                                              1
                                                                                                           1


                                                                                                                  0         0       0                    0               0
                                                                                                           0
                                                                                                                2007       2008    2009     2010     2011    2012       YTD
                                                                                                                                                                        2013


                                                                                           Note: Deals include all announced medical equipment deals from 2006
         Note: Deals include all announced medical equipment deals from 2006
                                                                                           onwards, GlobalData
         onwards, GlobalData


         YM BioSciences Inc., Medical Equipment, Deals By Region,                          YM BioSciences Inc., Medical Equipment, Deals By Market,
         2007 to YTD 2013                                                                  2007 to YTD 2013


                         3                                                                                 3
          No. of Deals




                                                                                            No. of Deals




                               3                                                                                       3
                         2                                                                                 2

                         1                                                                                 1
                                        0         0        0         0                                                                  0            0              0
                         0                                                                                 0
                             North    Asia-     Europe   Middle   South                                             Drug          Anesthes        Cardiova    Dental
                             Americ   Pacific             East     and                                             Delivery         ia and         scular     Devices
                               a                          and     Central                                          Devices        Respirato       Devices
                                                         Africa   Americ                                                              ry
                                                                    a                                                              Devices



         Note: Deals include all announced medical equipment deals from 2006               Note: Deals include all announced medical equipment deals from 2006
         onwards, GlobalData                                                               onwards, GlobalData


        YM BioSciences Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013
        Year                                                     No. of Deals                                                               Deal Value (US$ million)
        2007                                                                                                           NA                                                         NA
        2008                                                                                                           NA                                                          NA
        2009                                                                                                           NA                                                          NA
        2010                                                                                                            2                                                        49.20
        2011                                                                                                           NA                                                          NA
        2012                                                                                                            1                                                        80.50
        YTD 2013                                                                                                       NA                                                          NA
        Note: Deals include all announced medical equipment deals from 2006 onwards, deal values included wherever disclosed, GlobalData




YM BioSciences Inc. - Medical Equipment - Deals and Alliances                                                                                        Reference Code: GDME10230D
Profile
Source : www.globalcompanyintelligence.com                                                                                                                                            Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       YM BioSciences Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 .................................................................................. 4
       YM BioSciences Inc., Medical Equipment Deals By Type, 2007 to YTD 2013 ................................................................................... 5
       YM BioSciences Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013............................................................................... 6
       YM BioSciences Inc., Medical Equipment, Deals By Market, 2007 to YTD 2013 ............................................................................... 7
       YM BioSciences Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 ................................................................................ 8
       YM BioSciences Inc., Medical Equipment, Deal Details ..................................................................................................................... 9
          Equity Offering ................................................................................................................................................................................ 9
             YM BioSciences Completes Public Offering Of Common Stock For US$80 Million .................................................................... 9
             YM BioSciences Completes Underwritten Public Offering Of US$46 Million............................................................................. 11
             YM BioSciences Completes Private Placement Of US$3.2 Million ........................................................................................... 13
       YM BioSciences Inc. - Key Competitors ........................................................................................................................................... 15
       Key Employees ................................................................................................................................................................................ 16
       Locations And Subsidiaries .............................................................................................................................................................. 17
          Head Office ................................................................
				
DOCUMENT INFO
Description: YM BioSciences Inc. (YM BioSciences) is a life sciences product development company. It focuses on the advancement of three clinical-stage hematology and oncology products, namely, CYT387, nimotuzumab, and CYT997. CYT387 is a small molecule, dual inhibitor of the JAK1/JAK2 kinases, which is currently under Phase I/II trial is meant for the treatment of myelofibrosis patients; nimotuzumab is an EGFR-targeting monoclonal antibody, which is under late-stage clinical development is for the treatment of the patients with brain metastasis and for the palliative treatment of non-small cell lung cancer; CYT997 is a vascular disrupting agent, which is currently under Phase I/II clinical development is for the treatment of glioma patients. While CYT387 and CYT997 are owned by YM BioSciences, nimotuzumab is licensed to CIMYM BioSciences Inc. (YM's majority-owned joint venture). The company has its presence in Canada, Australia, Cuba, the US and the UK. YM BioSciences is headquartered in Mississauga, Ontario, Canada. The company intends to co-develop and/or license the rights for the manufacturing or marketing its products under development to the pharmaceutical companies in return for license fees and royalty payments. The company also intends to seek other in-licensing/acquisition opportunities in continuing its business strategy. In December 2012, the company has signed a definitive agreement with Gilead Sciences, Inc. under which the later will acquire the former for $2.95 per share in cash. YM BioSciences Inc. (YM) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and t
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.